Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis
Guan SY, Cai HY, Wang P, Lv TT, Liu LN, Mao YM, Zhao CN, Wu Q, Dan YL, Sam NB, Wang DG, Pan HF
International journal of rheumatic diseases · 34 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- National Natural Science Foundation of China
- Subvenciones
- National Natural Science Foundation of China (81872687); National Natural Science Foundation of China (81573222, 81872687); National Natural Science Foundation of China (81573222)
Según 1 financiador declarado.
Publicación
- Publicado
- 2019-08-30 · Int J Rheum Dis · vol. 22 · número 10 · págs. 1803–1813
- Editorial
- Wiley
- Citado
- 55 citas · más que el 79% de estudios similares · 1.4× el promedio de su campo
- Referencias
- 54 trabajos
- Acceso
- De pago
- Áreas de investigación
- Vitamin D Research Studies · Bone health and osteoporosis research · Thyroid Disorders and Treatments
- Palabras clave
- Medicine, Vitamin D and neurology, Publication bias, Internal medicine, Meta-analysis, Funnel plot, Confidence interval, Cochrane Library, Odds ratio, Subgroup analysis, Systemic lupus erythematosus, Lupus erythematosus, Gastroenterology, Strictly standardized mean difference, Immunology, Disease, Antibody
- MeSH
- humans, lupus erythematosus, systemic, vitamin d deficiency, vitamin d, severity of illness index, biomarkers
12 autores
- Shi‐Yang Guan🇨🇳Anhui Medical University
- Hongyan Cai🇨🇳Anhui Medical University; Second Affiliated Hospital of Anhui Medical University
- Peng Wang🇨🇳Anhui Medical University
- Tiantian Lv🇨🇳Chaohu Hospital of Anhui Medical University
- Lina Liu🇨🇳Anhui Medical University
- Yan‐Mei Mao🇨🇳Anhui Medical University
- Chan‐Na Zhao🇨🇳Anhui Medical University
- Qian Wu🇨🇳Anhui Medical University
- Yi‐Lin Dan🇨🇳Anhui Medical University
- Napoleon Bellua Sam🇨🇳Anhui Medical University
- Deguang Wang🇨🇳 · autor de correspondenciaAnhui Medical University; Second Affiliated Hospital of Anhui Medical University
- Hai‐Feng Pan🇨🇳 · autor de correspondenciaAnhui Medical University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Aim
The indicators for measuring vitamin D are various, and 25-hydroxyvitamin D (25(OH)D) is considered as the optimal indicator of total vitamin D levels. In this study, we aim to deeply explore the 25(OH)D status in systemic lupus erythematosus (SLE) patients, and evaluate its relation to SLE risk and disease severity.
Methods
Literature about 25(OH)D status and its associations with SLE were searched in Pubmed, Embase and Cochrane Library databases. Standardized mean difference (SMD), odds ratio (OR) and corresponding 95% confidence interval (95% CI) were illustrated by forest plots, and correlation coefficients (r) were combined by generic inverse variance method. Heterogeneity and publication bias were quantified by I-squared (I2 ) test, funnel plot and Egger's test, respectively. Sensitivity analyses were further examined by leave-one-out method.
Results
Nineteen articles were included into our meta-analysis. The overall results showed that compared with the healthy controls, the circulating 25(OH)D levels were significantly lower in SLE patients (pooled SMD = -1.63, 95% CI: -2.51 to -0.76). Subgroup analysis revealed that compared with the healthy controls, SLE patients of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) ≥ 10, Arab and European ethnicity, all 4 seasons, no vitamin D supplement, had significantly lower circulating 25(OH)D levels; no significant differences were observed in SLE patients of SLEDAI < 10, mixed ethnicity, spring, summer, vitamin D supplement, respectively; no matter the changes of age, disease duration, and the therapy of corticosteroid or immunosuppressive or neither, circulating 25(OH)D levels were significantly reduced in SLE patients. The deficiency, insufficiency and sufficiency of vitamin D could significantly elevate, slightly decrease (not significantly), significantly decrease SLE risk, respectively (pooled OR = 4.37, 95% CI: 1.49 to 12.84; pooled OR = 0.52, 95% CI: 0.22 to 1.26; pooled OR = 0.31, 95% CI: 0.15 to 0.63). Circulating 25(OH)D levels were inversely associated with SLEDAI (pooled correlation coefficient = -0.50, 95% CI: -0.8278 to -0.1689).
Conclusions
Compared with healthy controls, 25(OH)D levels are significantly lower in SLE patients, which is influenced by disease activity, ethnicity, seasons and vitamin D supplement; no matter the change of age, diseases duration and therapy of corticosteroid or immunosuppressive or neither, 25(OH)D levels are significantly decreased in SLE patients; the deficiency, insufficiency and sufficiency of vitamin D could significantly elevate, slightly decrease, and significantly decrease SLE risk, respectively; and 25(OH)D levels inversely correlate with SLEDAI.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.